Thursday, February 1

Memo to PR department: you're fired.

I suspect someone is going to have trouble at Amyris Biotechnologies, who were set up with a grant from Bill Gates foundation to look into a malaria cure, after this article came out.

To quote:
"This was technology that was really great for the current application of making an anti-malarial drug and we said, great, pharmaceuticals, that's a wonderful model and then we realized, our market is in Africa and they make less than a dollar a day."

So they decided to aim for a more lucrative market as well

Does that give you any negative opinions on the company at all?

No comments: